- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Director, Public Affairs | New South Wales (NSW) | Australia | Corporate Affairs | General Management | Communications & Public Affairs | Dec 02, 2025 |
| Government Affairs Manager | Moscow (City) | Russian Fed. | Corporate Affairs | General Management | Communications & Public Affairs | Dec 02, 2025 |
| Head, Public Affairs, Denmark | Copenhagen | Denmark | Corporate Affairs | Audit & Compliance | Communications & Public Affairs | Dec 02, 2025 |
| Senior Manager, Associate Engagement - Site Communication | Hyderabad (Office) | India | Corporate Affairs | Communications | Communications & Public Affairs | Dec 02, 2025 |
| Sr Manager, Executive Communications | Toranomon (NPKK Head Office) | Japan | Corporate Affairs | Communications | Communications & Public Affairs | Dec 02, 2025 |
| Senior Lead or Lead, Public Affairs | Toranomon (NPKK Head Office) | Japan | International | Other | Communications & Public Affairs | Dec 02, 2025 |
| Director, Policy | Toranomon (NPKK Head Office) | Japan | International | Other | Communications & Public Affairs | Nov 30, 2025 |
| Director, Social Impact & Novartis Foundation (Japan) for the Promotion of Science | Toranomon (NPKK Head Office) | Japan | International | Other | Communications & Public Affairs | Nov 30, 2025 |
| Public Affairs Manager (f/m/d) | Vienna | Austria | Corporate Affairs | Audit & Compliance | Communications & Public Affairs | Nov 12, 2025 |
| Director, Public Affairs | Beijing (Beijing) | China | Corporate Affairs | Corporate & Division Services | Communications & Public Affairs | Nov 11, 2025 |
| Manager, Policy Communications | Washington, DC | USA | Corporate Affairs | Corporate & Division Services | Communications & Public Affairs | Oct 27, 2025 |
| Manager, TA Patient Advocacy | Shanghai (Shanghai) | China | Corporate Affairs | Communications | Communications & Public Affairs | Mar 04, 2025 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى